Skip to main content
. 2025 Dec 29;15(1):253. doi: 10.3390/jcm15010253
RCT randomized controlled trial
MDMA 3,4-methylenedioxymethamphetamine
LSD lysergic acid diethylamide
PTSD post-traumatic stress disorder
MD major depression
AUD alcohol use disorder
MDD major depressive disorder
SUD substance use disorder
BD bipolar disorder
DSM Diagnostic and Statistical Manual of Mental Disorders
ICD International Classification of Diseases
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PICOS Population, Intervention, Comparator, Outcomes, Study design
AMSTAR2 Assessment of Multiple Systematic Reviews 2
GRADE Grading of Recommendations Assessment, Development and Evaluation
OR odds ratio
RR risk ratio
CI confidence interval
SMD standardized mean difference
ED50 effective dose for 50% of population
ED95 effective dose for 95% of population
MD mean difference
SD standard deviation
ECG electrocardiogram
FDA Food and Drug Administration
CBT cognitive behavioral therapy
SSRIs selective serotonin reuptake inhibitors
CANMAT Canadian Network for Mood and Anxiety Treatments
CAPS Clinician-Administered PTSD Scale
BDI Beck Depression Inventory
SDS Sheehan Disability Scale
PSQI Pittsburgh Sleep Quality Index
DES Dissociative Experiences Scale
ADR adverse drug reaction
AE adverse event